Consumer Health Cancer / Immunology

Beckman Coulter Life Sciences and Illumina Launch Automated Solution for Faster, Comprehensive Oncology Genomic Profiling

    Beckman Coulter Life Sciences, a global leader in laboratory  automation and innovation, in partnership with Illumina, a leader in DNA...

 August 07, 2024 | News

GSK Singapore Secures HSA Approval for Jemperli Combo Therapy in Advanced Endometrial Cancer

GSK Singapore is pleased to announce that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperli (dostarlimab). Jemperli ...

 August 07, 2024 | News

Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...

 August 07, 2024 | News

JelloX Biotech Collaborates with Mayo Clinic to Enhance 3D Digital Imaging and AI Analysis for Precision Cancer Diagnosis

JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to f...

 August 01, 2024 | News

Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...

 July 30, 2024 | News

FDA Accepts Telix's NDA for TLX007-CDx, Expanding PSMA-PET Imaging Access

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)  announces that the United States (U.S.) Food and Drug Administration (FDA) has...

 July 24, 2024 | News

Amgen and NSG BioLabs Extend Golden Ticket Partnership, Doubling Applicants and Awarding PairX Bio for Innovation in Cancer Treatment

The Amgen Golden Ticket Award, now in its third year, showcases Amgen's and NSG BioLabs' efforts to support high-growth startups in a nurturing ecosystem...

 July 18, 2024 | News

ADM Korea to Submit IND for Niclosamide-Based Combination Therapy for Prostate Cancer

IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. Niclosamide-based metab...

 July 12, 2024 | News

Thermo Fisher and NCI Join Forces to Accelerate Precision Medicine Trials for AML and MDS

To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: T...

 July 12, 2024 | News

Surfix Diagnostics, NKI, and CRCbioscreen Collaborate to Enhance Colorectal Cancer Screening

Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announce a collaboration aimed at enhancing colorectal cancer (CRC) s...

 July 10, 2024 | News

Immorna Biotherapeutics to Launch Phase 1/2 Study of Novel mRNA Therapeutic for Cancer

Immorna Biotherapeutics, Inc. (Immorna), a clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics a...

 July 09, 2024 | News

Hinova Pharmaceuticals Secures FDA Fast Track Designation for HP518 in Treating AR+ Triple-Negative Breast Cancer

Hinova Pharmaceuticals  a leading biopharmaceutical company dedicated to developing innovative cancer therapies, today announced that the U.S. Food an...

 July 08, 2024 | News

APPIS Innovator Program 2024 Winners Announced

    The APPIS Innovator Program 2024 has concluded with an impressive showcase of 49 entries from 21 countries, each addressing critical barrie...

 July 04, 2024 | News

Genoks and Velsera Partner to Transform Cancer Diagnostics and Treatment in Turkey

Genoks, a leading Turkish genomics healthcare company, and Velsera, a global healthcare technology company offering a universal software platform to connec...

 July 01, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close